Several studies reported that chronic increase of VEGF-A in the heart led to increased cardiac angiogenesis and development of CH; therefore, VEGF-A has become a recognized marker for CH (Tirziu et al., 2007; Marneros, 2018; Kivelä et al., 2019). Here, VEGFA is linked to cyclic hematopoiesis.